EMAIL THIS PAGE TO A FRIEND

Applied and environmental microbiology

Verrucomicrobia are candidates for polysaccharide-degrading bacterioplankton in an arctic fjord of Svalbard.


PMID 24727271

Abstract

In Arctic marine bacterial communities, members of the phylum Verrucomicrobia are consistently detected, although not typically abundant, in 16S rRNA gene clone libraries and pyrotag surveys of the marine water column and in sediments. In an Arctic fjord (Smeerenburgfjord) of Svalbard, members of the Verrucomicrobia, together with Flavobacteria and smaller proportions of Alpha- and Gammaproteobacteria, constituted the most frequently detected bacterioplankton community members in 16S rRNA gene-based clone library analyses of the water column. Parallel measurements in the water column of the activities of six endo-acting polysaccharide hydrolases showed that chondroitin sulfate, laminarin, and xylan hydrolysis accounted for most of the activity. Several Verrucomicrobia water column phylotypes were affiliated with previously sequenced, glycoside hydrolase-rich genomes of individual Verrucomicrobia cells that bound fluorescently labeled laminarin and xylan and therefore constituted candidates for laminarin and xylan hydrolysis. In sediments, the bacterial community was dominated by different lineages of Verrucomicrobia, Bacteroidetes, and Proteobacteria but also included members of multiple phylum-level lineages not observed in the water column. This community hydrolyzed laminarin, xylan, chondroitin sulfate, and three additional polysaccharide substrates at high rates. Comparisons with data from the same fjord in the previous summer showed that the bacterial community in Smeerenburgfjord changed in composition, most conspicuously in the changing detection frequency of Verrucomicrobia in the water column. Nonetheless, in both years the community hydrolyzed the same polysaccharide substrates.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

G0750
D-(+)-Galactose, ≥99%
C6H12O6
G0625
D-(+)-Galactose, ≥98%
C6H12O6
G6404
D-(+)-Galactose, BioXtra, pH 5.0-7.0 (20 °C, 1 M in H2O), ≥99%
C6H12O6
G5388
D-(+)-Galactose, powder, anhydrous, BioReagent, suitable for cell culture, suitable for insect cell culture
C6H12O6
48260
D-(+)-Galactose, for microbiology, ≥99.0%
C6H12O6
15522
D-(+)-Galactose, meets analytical specification of Ph. Eur., BP
C6H12O6
A3131
D-(−)-Arabinose, ≥98%
C5H10O5
10850
D-(−)-Arabinose, for microbiology, ≥99.0%
C5H10O5
G5269
D-Glucuronic acid, ≥98% (GC)
C6H10O7
W360600
D-(+)-Xylose, ≥99%
C5H10O5
X1500
D-(+)-Xylose, ≥99%
C5H10O5
X3877
D-(+)-Xylose, BioXtra, ≥99%
C5H10O5
95729
D-(+)-Xylose, BioUltra, ≥99.0% (sum of enantiomers, HPLC)
C5H10O5
47253
D-(+)-Xylose, analytical standard
C5H10O5
201626
Fluoresceinamine, isomer I
C20H13NO5
1287700 Galactose, United States Pharmacopeia (USP) Reference Standard
C6H12O6
PHR1206
Galactose, Pharmaceutical Secondary Standard; Certified Reference Material
C6H12O6
G0050000
Galactose, European Pharmacopoeia (EP) Reference Standard
C6H12O6
ARK2176
Galactose, plant-derived, PharmaGrade, USP/NF, Ph Eur, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production.
C6H12O6
F2252
L-(−)-Fucose, ≥99%
C6H12O5
M8378
Maltotriose, ≥90% (HPLC)
C18H32O16
X0200000
Xylose, European Pharmacopoeia (EP) Reference Standard
C5H10O5